title: Binding to the open conformation of HIV-1 protease.
abstract: A recent crystal structure of HIV-1 protease (HIVp) was the first to experimentally observe a ligand targeting an open-flap conformation. Researchers studying a symmetric pyrrolidine inhibitor found that two ligands cocrystallized with the protease, forcing an unusual configuration and unique crystallographic contacts. One molecule is centered in the traditional binding site (α pose) and the other binds between the flaps (β pose). The ligands stack against each other in a region termed the "eye" site. Ligands bound to the eye site should prevent flap closure, but it is unclear if the pyrrolidine inhibitors or the crystal packing are causing the open state. Molecular dynamics simulations were used to examine the solution-state behavior of three possible binding modes: the ternary complex of HIVp+αβ and the binary complexes, HIVp+α and HIVp+β. We show that HIVp+α is the most stable of the three states. During conformational sampling, α takes an asymmetric binding pose, with one naphthyl ring occupying the eye site and the other reoriented down to occupy positions seen with traditional inhibitors. This finding supports previous studies that reveal a requirement for asymmetric binding at the eye site. In fact, if the α pose is modified to splay both naphthyl rings across the binding site like traditional inhibitors, one ring consistently flips to occupy the eye site. Our simulations reveal that interactions to the eye site encourage a conformationally restrained state, and understanding those contacts may aid the design of ligands to specifically target alternate conformations of the protease.
authors: Department of Medicinal Chemistry, University of Michigan, Ann Arbor, Michigan 48109-1065, USA.
authors: Katrina W
authors: KW
authors: Lexa
authors: Heather A
authors: HA
authors: Carlson
references: J Comput Chem. 2004 Jul 15;25(9):1157-74
references: 15116359
references: Proteins. 2005 Jan 1;58(1):119-25
references: 15521062
references: Drugs. 2009;69(4):477-503
references: 19323590
references: Nucleic Acids Res. 2007 Jul;35(Web Server issue):W375-83
references: 17452350
references: Biopolymers. 2008 Aug;89(8):643-52
references: 18381626
references: Curr Pharm Des. 2007;13(3):271-85
references: 17313361
references: Drug Discov Today. 2007 Feb;12(3-4):132-8
references: 17275733
references: Structure. 1999 Sep 15;7(9):1047-55
references: 10508781
references: Proteins. 2006 Nov 15;65(3):712-25
references: 16981200
references: Proteins. 1998 Jul 1;32(1):7-16
references: 9672038
references: ChemMedChem. 2008 Sep;3(9):1337-44
references: 18720485
references: IEEE Trans Pattern Anal Mach Intell. 1979 Feb;1(2):224-7
references: 21868852
references: J Comput Chem. 2002 Dec;23(16):1623-41
references: 12395429
references: J Chem Theory Comput. 2007 Nov;3(6):2312-34
references: 26636222
references: Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10037-41
references: 11517324
references: Protein Sci. 2002 Feb;11(2):221-32
references: 11790832
references: Chem Biol Drug Des. 2010 Mar;75(3):257-68
references: 20659109
references: Structure. 2005 Dec;13(12):1887-95
references: 16338417
references: Biochemistry. 2007 Dec 25;46(51):14865-77
references: 18052195
references: J Med Chem. 2010 Jan 28;53(2):521-38
references: 19785437
references: Nat Struct Biol. 1995 Apr;2(4):274-80
references: 7796263
references: Protein Sci. 2004 Apr;13(4):1108-23
references: 15044738